Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XCCNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCCNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FK.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FK.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.21.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.21.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.21.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FP.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FP.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.92NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.92NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.92NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.42NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.42NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.42NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.35.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.35.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.35.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.2.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.3.2.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LU.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LU.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LU.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LF.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LF.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.16.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.16.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.16.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LW.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LW.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LP.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.3.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.3.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.3.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
ML.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
ML.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
ML.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used